Best Pediatric Oncology Doctors in Пекин, China — TOP 6

Dr. Wu Minyuan is a specialist at the clinic and a Professor/Chief Physician/Doctoral Supervisor in pediatric hematology at Beijing Jingdu Children’s Hospital. She has over 50 years of clinical and academic leadership and is described as a pioneer in childhood leukemia treatment. Her differentiator is protocol leadership: as former Director of the Hematology Center at Beijing Children’s Hospital, she spearheaded national protocols that raised 5-year disease-free survival for pediatric ALL to over 80%, alongside work on risk-stratified chemotherapy and multi-center trials integrating chemotherapy, immunotherapy, and targeted therapies.

Dr. Duan Weihong is a specialist at the clinic and Director of the Oncology Surgery Department at Beijing Jingdu Children’s Hospital. He is known for pioneering ultra-high-difficulty hepatobiliary oncology surgeries, including complex transplant-integrated procedures. His pediatric-focused differentiator is a vascular–transplant–tumor integrated surgical system for cases such as hepatoblastoma, including cryopreserved allogeneic vascular grafting and anticoagulation planning to reduce anastomotic thrombosis.

Dr. Wu Nanhai is a specialist at the clinic and holds leadership roles as Deputy Director of the Hematology and Oncology Center and Director of Ward 9 at Beijing Jingdu Children’s Hospital. He has nearly 40 years of clinical and academic leadership experience, including early work as Deputy Director of Pediatrics at the Sixth Medical Center of the PLA General Hospital (formerly the Navy General Hospital). His differentiator is combined clinical leadership and academic influence, including Executive Deputy Editor-in-Chief of Chinese Journal of Pediatric Blood and Oncology and membership in major pediatric oncology/hematology professional groups.

Dr. Tang Suoqin is a specialist at the clinic and Senior Consultant/Distinguished Professor in the Department of Hematology and Oncology at Beijing Jingdu Children’s Hospital. With over 30 years of clinical and academic leadership, he focuses on high-risk neuroblastoma and refractory pediatric solid tumors. His differentiator includes involvement in a Nature Communications 2024 Phase I/II trial (“A Phase I/II Trial”) and ongoing work on AI-driven precision oncology platforms to broaden access to therapies.

Dr. Xiao Juan is a specialist at the clinic and Chief Physician/Ward Director of Ward 9 in the Hematology Oncology Center at Beijing Jingdu Children’s Hospital. With nearly 20 years of clinical experience, she focuses on HSCT and cellular immunotherapy for refractory childhood blood diseases, including refractory acute B lymphoblastic leukemia. Her differentiator includes academic recognition—an Excellent Paper Award at the 28th National Academic Conference on Pediatrics of the Chinese Medical Association for refractory acute B lymphoblastic leukemia in children.

Dr. Liu Hongyan is a specialist at the clinic and an Associate Chief Physician in the Department of Hematology and Oncology at Beijing Jingdu Children’s Hospital. She has 15 years of clinical experience focused on childhood blood disorders and cancers. Her differentiator is clinical recognition—she received an Outstanding Physician Award at the former Beijing Armed Police General Hospital’s Pediatric Department—and her training includes a Master’s in Pediatrics from Guangxi Medical University (2010).